Incyte
Speed Read
0%
300 WPM
-- remaining
Incyte is a biopharmaceutical company focused on oncology and inflammation, known for developing JAK inhibitors for cancer and autoimmune diseases. The company's drug discovery capabilities and strategic partnerships have built a diverse portfolio. Incyte's success with targeted therapies demonstrates the value of understanding disease biology.